NCT04939987

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy: A Randomized Controlled Trial

• Status: Withdrawn
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Wake Forest University Health Sciences · Academic / Other
• Sex: Male
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

Detailed description

This study will conduct a randomized control double-blind clinical trial to evaluate an opioid versus a non-opioid pathway of gabapentin, ketorolac, and acetaminophen in treating postoperative pain following robot-assisted radical prostatectomy (RARP).

Conditions

• Radical Prostatectomies

Interventions

Type	Name	Description
DRUG	Tramadol	Opioid Control Cohort (One treatment selected)
DRUG	Gabapentin	Experimental Cohort (Multimodal Approach)
DRUG	Hydrocodone-Acetaminophen	Opioid Control Cohort (One treatment selected)
DRUG	Oxycodone-Acetaminophen	Opioid Control Cohort (One treatment selected)
DRUG	Ketorolac	Experimental Cohort (Multimodal Approach)
DRUG	Acetaminophen	Experimental Cohort (Multimodal Approach)
DRUG	Ketorolac tromethamine	Experimental Cohort (Multimodal Approach)
DRUG	Ketamine	Experimental Cohort (Multimodal Approach)

Timeline

• Start date: 2022-08-01
• Primary completion: 2022-10-01
• Completion: 2022-10-01
• First posted: 2021-06-25
• Last updated: 2022-09-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study